BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 25335723)

  • 21. Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer.
    Takakura K; Koido S; Kan S; Yoshida K; Mori M; Hirano Y; Ito Z; Kobayashi H; Takami S; Matsumoto Y; Kajihara M; Misawa T; Okamoto M; Sugiyama H; Homma S; Ohkusa T; Tajiri H
    Anticancer Res; 2015 Jan; 35(1):555-62. PubMed ID: 25550602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?
    Ishikawa O; Wada H; Ohigashi H; Doki Y; Yokoyama S; Noura S; Yamada T; Sasaki Y; Imaoka S; Kasugai T; Matsunaga T; Takenaka A; Nakaizumi A
    Ann Surg; 2003 Jul; 238(1):103-10. PubMed ID: 12832972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [WT1 Class I Peptide/WT1 Class II Peptide Pulsed Dendritic Cell Therapy Efficacy in 60 Patients with a Wide Range of Advanced Cancers].
    Kato Y
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1252-1255. PubMed ID: 27760951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
    Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
    Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [WT1-targeting cancer vaccine].
    Sugiyama H
    Nihon Rinsho; 2012 Dec; 70(12):2105-13. PubMed ID: 23259381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of small bowel cancer with positive peritoneal cytology and five-year recurrence-free survival].
    Matsumura A; Shimizu K; Nishibeppu K; Matsuyama T; Ogino S; Takemura M; Mugitani T; Ishida H; Akami T; Okano S
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2444-6. PubMed ID: 25731552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spleen-preserving laparoscopic distal pancreatectomy for cystic adenoma.
    Watanabe Y; Sato M; Kikkawa H; Shiozaki T; Yoshida M; Yamamoto Y; Kawachi K
    Hepatogastroenterology; 2002; 49(43):148-52. PubMed ID: 11941940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case report of curative resection for gastric cancer with peritoneal dissemination successfully treated by combined chemotherapy of S-1 and paclitaxel].
    Yamaki S; Iwata S; Ohtsuka K; Kitaoka A; Masumoto H; Katoh H
    Gan To Kagaku Ryoho; 2008 May; 35(5):821-3. PubMed ID: 18487921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial.
    Nagai K; Adachi T; Harada H; Eguchi S; Sugiyama H; Miyazaki Y
    Anticancer Res; 2020 Oct; 40(10):5765-5776. PubMed ID: 32988904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy].
    Nishiura H; Ishii K; Nonami M; Shigemori M; Katsurada A; Azechi H; Kondo M; Tojo M; Nishikawa K; Asagoe K; Otani Y; Inoue F; Suwa H; Saiga T
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2057-60. PubMed ID: 17197753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer.
    Yachida S; Fukushima N; Sakamoto M; Matsuno Y; Kosuge T; Hirohashi S
    Br J Surg; 2002 May; 89(5):573-8. PubMed ID: 11972546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Selection of methods for diagnosis and treatment of pancreatic cancer].
    Ozaki H; Kinoshita T; Kosuge T; Shimada K; Yamamoto J; Inoue K
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2311-8. PubMed ID: 1463336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effect induced by dendritic cell (DC)-based immunotherapy against peritoneal dissemination of the hamster pancreatic cancer.
    Takigawa Y; Akiyama Y; Maruyama K; Sugiyama K; Uchida E; Kosuge T; Ueda M; Kitajima M; Yamaguchi K
    Cancer Lett; 2004 Nov; 215(2):179-86. PubMed ID: 15488636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Two Cases Pancreatic Carcinoma Detected Incidentally during Treatment of Acute Abdomen from Other Causes].
    Fujisaki S; Takashina M; Tomita R; Sakurai K; Takayama T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1662-1664. PubMed ID: 28133091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of dendritic cell vaccines pulsed with Wilms' tumour-1 peptide antigen on the survival of patients with advanced non-small cell lung cancers.
    Takahashi H; Okamoto M; Shimodaira S; Tsujitani S; Nagaya M; Ishidao T; Kishimoto J; Yonemitsu Y;
    Eur J Cancer; 2013 Mar; 49(4):852-9. PubMed ID: 23245331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy Targeting WT1: Designing a Protocol for WT1 Peptide-Based Cancer Vaccine.
    Nishida S; Sugiyama H
    Methods Mol Biol; 2016; 1467():221-32. PubMed ID: 27417973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effectiveness of reduction surgery and gemcitabine for multiple bowel obstructions due to peritoneal dissemination of pancreatic carcinoma with liver metastasis--a case report].
    Makino H; Kametaka H; Yasuno K; Koyama T; Seike K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2416-8. PubMed ID: 20037441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of two re-resections for peritoneal recurrence of pancreatic cancer].
    Kikuchi T; Kenjo A; Kimura T; Anazawa T; Sato T; Sato N; Haga J; Watanabe J; Tsuchiya T; Saito T; Gotoh M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2166-8. PubMed ID: 25731458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estimation of peritoneal dissemination in patients with unresectable advanced or recurrent colorectal cancer who underwent curative resection after combination chemotherapy].
    Mizota S; Ikeda S; Yamauchi M; Imaoka Y; Mashima H; Okimoto S; Takakura Y; Noma M; Ohara M; Oishi K; Kohashi T; Fudaba Y; Ishimoto T; Matsugu Y; Nakahara H; Urushihara T; Shinozaki K; Itamoto T
    Gan To Kagaku Ryoho; 2014 May; 41(5):595-600. PubMed ID: 24917004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.